PDF icon PDF herunterladen
Z Gastroenterol 2014; 52(1): 64
DOI: 10.1055/s-0034-1366796
Erratum
© Georg Thieme Verlag KG Stuttgart · New York

Randomized Controlled Treatment Trial of Irritable Bowel Syndrome with a Probiotic E.-coli Preparation (DSM17252) Compared to Placebo

Eine randomisierte, kontrollierte Behandlungsstudie beim Reizdarmsyndrom mit einer probiotischen E.-coli-Präparation (DSM17252) im Vergleich zu Placebo
P. Enck
1   Internal Medicine VI, University Medical Hospital, Tübingen
,
K. Zimmermann
2   Symbio Herborn Group GmbH, Herborn
,
G. Menke
3   PAZ Arzneimittel-Entwicklungsgesellschaft mbH, Frankfurt/M.
,
S. Klosterhalfen
1   Internal Medicine VI, University Medical Hospital, Tübingen
› Institutsangaben
Weitere Informationen

Korrespondenzadresse

Prof. Dr. Paul Enck
Department of Internal Medicine VI, Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen
Frondsbergstr. 23
72076 Tübingen
Germany   
Telefon: ++ 49/70 71/2 98 91 18   
Fax: ++ 49/70 71/29 43 82   

Publikationsverlauf

Publikationsdatum:
25. Juni 2014 (online)

Auch verfügbar aufeRef
 
 als PDF herunterladen Lizenzen und Reprints

Originalartikel zu diesem Erratum:

Randomized Controlled Treatment Trial of Irritable Bowel Syndrome with a Probiotic E.-coli Preparation (DSM17252) Compared to PlaceboZ Gastroenterol 2009; 47(02): 209-214
DOI: 10.1055/s-2008-1027702

Erratum „P. Enck, K. Zimmermann, G. Menke, S. Klosterhalfen. Randomized Controlled Treatment Trial of Irritable Bowel Syndrome with a Probiotic E.-coli Preparation (DSM17252) Compared to Placebo. Z Gastroenterol; 2009; 47(2): 209-214, DOI: 10.1055/s-2008-1027702“

Table 2 accidentally reports data from another study. The correct table 2 reads as follows:

Table 2

Demographic data of patients in the drug and the placebo arm of the study.

Drug

Placebo

No of patients

N = 148

N = 150

Females

N = 86

N = 81

Age

48.71 (19 - 74)

48.25 (18 - 82)

Weight (kg)

69.86 (49 - 101)

70.37 (44 - 104)

BMI

24.51 (19.63 - 34.17)

24.57 (18.07 - 37.92)

No rescue medication incidences in both study arms, two cases of premature study termination because of adverse events, both in the drug arm.


 

 

Korrespondenzadresse

Prof. Dr. Paul Enck
Department of Internal Medicine VI, Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen
Frondsbergstr. 23
72076 Tübingen
Germany   
Telefon: ++ 49/70 71/2 98 91 18   
Fax: ++ 49/70 71/29 43 82   


  Lizenzen und Reprints